Tris Pharma, Inc. v. Actavis Laboratories FL, Inc. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP

Almost four years ago, in a relatively rare occurrence based on there being an insufficient factual record to permit proper appellate review, the Federal Circuit vacated a District...

Related Keywords

,District Court ,Attention Deficit Hyperactive Disorder ,Application Publication ,Tris Pharma ,Federal Circuit ,Judge Chen ,Judges Newman ,Citing Gechter ,Chief Judge Moore ,Circuit Judges Chen ,Circuit Judge ,